The Architecture of Emergency: Ibogaine & Psychedelic Use in the Anthropocene Era - Clare S. Wilkins

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Agregado by Siulwon
7 Vistas
Psychedelic Science Summit: Austin, Texas (November 1-3, 2019)

Speaker: Clare S. Wilkins

Ibogaine, as well as other psychedelics, have been gaining traction within the medical model, as the shamanic approach continues. Both methods can emphasize a power dynamic wherein the patient or client forfeits agency to the doctor or shaman, or to the medicine itself, and the remedy is often seen as coming from outside, rather than from within. This perspective can result in people continuing to feel the need for treatment, remaining sick, and continuing to harm themselves unconsciously, in order to receive continued care or simply to connect. Many see ibogaine as a fast, one-time fix, which correlates with a culture that emphasizes production, imbalanced power structures, human arrogance, rapid communication, and results. This can be dangerous, as adverse events occur during or after treatment when spaciousness, details, and nuances are ignored. We have found that moving away from the frenetic pace of mechanical, modern life into a safe territory, and delving into the inner mechanics of the unconscious mind, beyond the walls of ego protection, requires presence, compassionate support, continued connection, and a radical sense of inclusivity in order to truly accept oneself and others; in order to evolve during these dire times.

Clare S. Wilkins is a former intravenous IV drug user & methadone patient who shed those chemical dependencies with the aid of ibogaine in 2005. As founder of Pangea Biomedics, she has facilitated over 800 treatments with a diverse team and has collaborated with MAPS to study the long-term effects of patients undergoing detoxification therapy with ibogaine for opiates. (Brown, Alper M.D., 2017)

Since 2010 she has been an active board member of The Global Ibogaine Therapy Alliance (GITA); is co-author of the Clinical Guidelines for Ibogaine-Assisted Detoxification, a comprehensive risk-management resource & minimum standard of care for opioid detoxification. She is also co-author of a noteworthy case study (Wilkins, Bouso, Ph.D., et al 2017) published in the Journal of Psychedelic Studies. Mentored by Howard Lotsof, she is committed to advancing scientific research of iboga, including ibogaine, its alkaloids & analogs. She is currently collaborating with ICEERS in Spain, where a Phase 2 safety & efficacy study, using ibogaine for methadone patients has been approved, utilizing the cumulative administration method she developed over 13 years of clinical practice in Mexico.

Clare is also part of a cutting edge cohort of experts who are advancing Parkinson's Disease treatment, utilizing a successful combination of ibogaine, orthomolecular medicine and nootropics. As these case studies build, data gathered will contribute to new methods that can become open-source material for the safest and best outcomes. As a member of INPUD, an international drug user rights organization, Clare is devoted to reducing stigma & harm, promoting the health, dignity, and cognitive liberty for people who use drugs, and every human’s basic right to compassion-based medicine.

Learn more:

Hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS):
Otras Drogas Other languages Maps Social

Deja tu comentario

Inicia Sesión o Registrate para dejar comentarios.


Anímate! Se el primero en comentar este video